<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Overview of dermatologic problems following liver transplantation</title><link href="/z/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/z/d/css/icofont.min.css" rel="stylesheet"/><link href="/z/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/z/d/css/animate.css" rel="stylesheet"/><link href="/z/d/css/owl.carousel.css" rel="stylesheet"/><link href="/z/d/css/magnific-popup.css" rel="stylesheet"/><link href="/z/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/z/d/css/style.css" rel="stylesheet"/><link href="/z/d/css/rtl_edited.css" rel="stylesheet"/><link href="/z/d/css/responsive.css" rel="stylesheet"/><link href="https:///uptodate_assets/main.css" rel="stylesheet"/>
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>
<meta content="" name="description"/>
<link href="/z/d/img/favicon.png" rel="icon" type="image/png">
</link></head>
<body>
<!-- Start Main Menu Area -->
<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>
<section class="teacher-area ptb-10">
<div class="container">
</div>
<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Overview of dermatologic problems following liver transplantation</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Overview of dermatologic problems following liver transplantation</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Author:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Jean-François Dufour, MD</a></dd><dt><span> </span>Section Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Robert S Brown, Jr, MD, MPH</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Kristen M Robson, MD, MBA, FACG</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> May 27, 2022.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H1"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>Liver transplantation recipients, like other solid organ transplantation recipients, have an increased risk of dermatologic problems due to their need for long-term immunosuppression, and they benefit from pre-and post-transplantation screenings. Management by a dermatologist and dermatologic care should be integrated into the comprehensive, multidisciplinary care of liver transplantation recipients [<a href="#rid1">1,2</a>]. </p><p>Dermatologic conditions are common in liver transplantation recipients [<a href="#rid3">3</a>]. Cutaneous findings include aesthetic alterations, infections, precancerous lesions, and malignancies. The severity of skin alterations ranges from benign, unpleasant changes to life-threatening conditions [<a href="#rid4">4-6</a>]. In addition to skin cancer screening, diagnosis, and management, visits with a dermatologist serve to educate and improve the patient's sun-protection behavior.</p><p>Among all solid organ transplantations, liver transplantation requires the least amount of immunosuppression [<a href="#rid7">7</a>]. As a result, patients who have undergone liver transplantation tend to have fewer dermatologic complications compared with other solid organ transplantation recipients [<a href="#rid8">8</a>]. However, due to the large volume of the liver, patients undergoing liver transplantation receive more donor lymphocytes than kidney, heart, or lung transplantation recipients. Because of the immunosuppression, the transplanted lymphocytes proliferate and, rarely, trigger graft-versus-host disease [<a href="#rid9">9,10</a>].</p><p>This topic will provide an overview of dermatologic disorders following liver transplantation. A detailed discussion of skin cancer following solid organ transplantation and the general management of patients following liver transplantation are discussed separately. (See  <a class="medical medical_review" href="/z/d/html/7304.html" rel="external">"Malignancy after solid organ transplantation"</a> and  <a class="medical medical_review" href="/z/d/html/16339.html" rel="external">"Prevention and management of skin cancer in solid organ transplant recipients"</a> and  <a class="medical medical_review" href="/z/d/html/4589.html" rel="external">"Liver transplantation in adults: Long-term management of transplant recipients"</a>.)</p><p class="headingAnchor" id="H457175085"><span class="h1">EFFECT OF TRANSPLANTATION ON PREEXISTING DERMATOLOGIC DISORDERS</span><span class="headingEndMark"> — </span>Patients undergoing liver transplantation may have preexisting dermatologic disorders that are subsequently affected by transplantation. In many cases, the disorders improve either as a result of removal of the diseased liver or because of the immunosuppression patients receive [<a href="#rid11">11</a>].</p><p class="headingAnchor" id="H65718620"><span class="h2">Dermatologic manifestations of liver disease</span><span class="headingEndMark"> — </span>In patients with dermatologic lesions related to cirrhosis or associated with specific forms of liver disease, transplantation often leads to improvement in the dermatologic findings (<a class="graphic graphic_table graphicRef60813" href="/z/d/graphic/60813.html" rel="external">table 1</a>).</p><p>Most of the nonspecific mucocutaneous lesions linked to cirrhosis, such as palmar erythema, spider nevi, and pruritus, disappear in the weeks following the liver transplantation [<a href="#rid12">12</a>], though skin pigmentation, clubbing, and fingernail changes [<a href="#rid13">13</a>] may take several months to regress. Dupuytren's contractures are usually irreversible (<a class="graphic graphic_picture graphicRef70486" href="/z/d/graphic/70486.html" rel="external">picture 1</a>). (See  <a class="medical medical_review" href="/z/d/html/1253.html" rel="external">"Cirrhosis in adults: Etiologies, clinical manifestations, and diagnosis", section on 'Physical examination'</a>.)</p><p>Specific forms of liver disease may also be associated with dermatologic manifestations (<a class="graphic graphic_table graphicRef60813" href="/z/d/graphic/60813.html" rel="external">table 1</a>). Although the clinical courses of these disorders after liver transplantation have not been well described, the available data suggest that many of these conditions improve. Examples include:</p><p class="bulletIndent1"><span class="glyph">●</span>Autoimmune hepatitis – Alopecia [<a href="#rid14">14</a>] and vitiligo (<a class="graphic graphic_picture graphicRef70838" href="/z/d/graphic/70838.html" rel="external">picture 2</a>) [<a href="#rid15">15</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Chronic cholestatic liver disease – Xanthomas and xanthelasmas (<a class="graphic graphic_picture graphicRef75157" href="/z/d/graphic/75157.html" rel="external">picture 3</a>) [<a href="#rid16">16</a>] (see  <a class="medical medical_review" href="/z/d/html/3621.html" rel="external">"Clinical manifestations, diagnosis, and prognosis of primary biliary cholangitis", section on 'Physical examination'</a>). </p><p></p><p class="bulletIndent1">However, planar xanthomas have been reported in liver transplant recipients who develop cholangiopathy [<a href="#rid17">17</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Hepatitis C virus infection – Cryoglobulinemia, porphyria cutanea tarda (<a class="graphic graphic_picture graphicRef74528" href="/z/d/graphic/74528.html" rel="external">picture 4</a>), leukocytoclastic vasculitis (<a class="graphic graphic_picture graphicRef58626" href="/z/d/graphic/58626.html" rel="external">picture 5</a>), and lichen planus (<a class="graphic graphic_picture graphicRef76383" href="/z/d/graphic/76383.html" rel="external">picture 6</a>) [<a href="#rid18">18</a>].</p><p></p><p class="headingAnchor" id="H65718626"><span class="h2">Coexisting dermatologic disorders</span><span class="headingEndMark"> — </span>Patients with liver disease may have dermatologic disorders that are not the result of their liver disease, such as psoriasis and atopic dermatitis. There may be shared risk factors for dermatologic disorders and liver disease (eg, alcohol use is a risk factor for both psoriasis and alcohol-associated liver disease [<a href="#rid19">19,20</a>]). In addition, the treatment of the dermatologic disorder could be associated with hepatotoxicity (eg, <a class="drug drug_general" data-topicid="9630" href="/z/d/drug information/9630.html" rel="external">methotrexate</a> [<a href="#rid21">21,22</a>]). In some cases, the immunosuppressive agents used following liver transplantation, such as glucocorticoids and calcineurin inhibitors, may also lead to improvement in dermatologic disorders. However, rapid tapering of immunosuppression could lead to exacerbations of dermatologic disorders. Management of psoriasis and other chronic dermatologic conditions is discussed separately. (See  <a class="medical medical_review" href="/z/d/html/5666.html" rel="external">"Treatment of psoriasis in adults"</a> and  <a class="medical medical_review" href="/z/d/html/1730.html" rel="external">"Treatment of atopic dermatitis (eczema)"</a>.)</p><p class="headingAnchor" id="H65718632"><span class="h2">Previously treated skin cancer</span><span class="headingEndMark"> — </span>Patients undergoing liver transplantation may have a history of treated skin cancer. While a history of treated skin cancer is not an absolute contraindication to transplantation, if a patient develops a recurrence of the cancer, a reduction in immunosuppression may be needed, increasing the risk of graft rejection [<a href="#rid23">23</a>]. (See  <a class="medical medical_review" href="/z/d/html/16339.html" rel="external">"Prevention and management of skin cancer in solid organ transplant recipients"</a> and  <a class="medical medical_review" href="/z/d/html/4585.html" rel="external">"Liver transplantation in adults: Patient selection and pretransplantation evaluation", section on 'Contraindications'</a>.)</p><p class="headingAnchor" id="H457175251"><span class="h1">DERMATOLOGIC COMPLICATIONS AFTER LIVER TRANSPLANTATION</span><span class="headingEndMark"> — </span>New dermatologic lesions may develop following liver transplantation, often related to the patient's immunosuppression [<a href="#rid24">24,25</a>].<strong> </strong>Dermatologic complications include cosmetic side effects of immunosuppressive therapy (<a class="graphic graphic_table graphicRef56452" href="/z/d/graphic/56452.html" rel="external">table 2</a>), skin infections (<a class="graphic graphic_table graphicRef69874" href="/z/d/graphic/69874.html" rel="external">table 3</a> and <a class="graphic graphic_table graphicRef76657" href="/z/d/graphic/76657.html" rel="external">table 4</a> and <a class="graphic graphic_table graphicRef55662" href="/z/d/graphic/55662.html" rel="external">table 5</a>), skin cancer (<a class="graphic graphic_table graphicRef72557" href="/z/d/graphic/72557.html" rel="external">table 6</a>), and graft-versus-host disease (<a class="graphic graphic_table graphicRef67318" href="/z/d/graphic/67318.html" rel="external">table 7</a>).</p><p>The following questions may be helpful to estimate a patient's risk for dermatologic complications following liver transplantation:</p><p class="bulletIndent1"><span class="glyph">●</span>Were there pretransplantation dermatologic problems?</p><p class="bulletIndent1"><span class="glyph">●</span>Is the patient's skin sensitive to light?</p><p class="bulletIndent1"><span class="glyph">●</span>What is the patient's typical exposure to sunlight?</p><p class="bulletIndent1"><span class="glyph">●</span>What is the patient's exposure to animals?</p><p class="bulletIndent1"><span class="glyph">●</span>Are serologies for herpes simplex I, herpes simplex II, herpes virus 8, hepatitis C virus, or syphilis positive?</p><p class="bulletIndent1"><span class="glyph">●</span>What is the degree of immunosuppression?</p><p class="bulletIndent1"><span class="glyph">●</span>What is the length of the follow-up since the liver transplantation?</p><p></p><p class="headingAnchor" id="H457175265"><span class="h2">Cosmetic problems and side effects of immunosuppressive therapy</span><span class="headingEndMark"> — </span>Many of the immunosuppressive drugs used in the transplantation setting have been associated with mucocutaneous complications, such as acne, cushingoid appearance, and gingival hyperplasia (<a class="graphic graphic_table graphicRef56452" href="/z/d/graphic/56452.html" rel="external">table 2</a>). The complexity of immunosuppressive regimens often makes it difficult to identify a specific drug as the cause of a dermatologic complication.</p><p class="headingAnchor" id="H457175332"><span class="h2">Dermatologic infections</span><span class="headingEndMark"> — </span>Dermatologic infections after liver transplantation can be challenging [<a href="#rid5">5</a>]. Dermatologic infections may be due to bacteria [<a href="#rid26">26</a>] (<a class="graphic graphic_table graphicRef69874" href="/z/d/graphic/69874.html" rel="external">table 3</a>), mycobacteria (<a class="graphic graphic_table graphicRef69874" href="/z/d/graphic/69874.html" rel="external">table 3</a>), viruses (<a class="graphic graphic_table graphicRef76657" href="/z/d/graphic/76657.html" rel="external">table 4</a>), or fungi (<a class="graphic graphic_table graphicRef55662" href="/z/d/graphic/55662.html" rel="external">table 5</a>), and often involve several infectious agents, such as skin coinfection with herpes virus and cytomegalovirus. Another frequently seen problem is the development of warts due to papillomavirus infection. (See  <a class="medical medical_review" href="/z/d/html/1396.html" rel="external">"Infection in the solid organ transplant recipient"</a>.)</p><p>In the transplantation setting, some of these skin lesions lose their characteristic macroscopic appearance, making the diagnosis more difficult than in the nontransplantation setting. As a result, systematic microbiologic and histologic tests should not be delayed. Common bacterial and viral infections predominate early (less than three months) after transplantation, while rarer bacteria and opportunistic agents, such as fungi (<a class="graphic graphic_picture graphicRef61124" href="/z/d/graphic/61124.html" rel="external">picture 7</a>), are seen later [<a href="#rid27">27-30</a>].</p><p class="headingAnchor" id="H457175338"><span class="h2">Skin cancer</span><span class="headingEndMark"> — </span>Skin cancers, including squamous cell carcinoma (the most common form) (<a class="graphic graphic_picture graphicRef60026" href="/z/d/graphic/60026.html" rel="external">picture 8</a>), basal cell carcinoma (<a class="graphic graphic_picture graphicRef65704" href="/z/d/graphic/65704.html" rel="external">picture 9</a>), melanoma (<a class="graphic graphic_picture graphicRef74278" href="/z/d/graphic/74278.html" rel="external">picture 10</a>) [<a href="#rid31">31,32</a>] and Merkel cell carcinoma (<a class="graphic graphic_picture graphicRef70535" href="/z/d/graphic/70535.html" rel="external">picture 11</a> and <a class="graphic graphic_picture graphicRef50573" href="/z/d/graphic/50573.html" rel="external">picture 12</a> and <a class="graphic graphic_picture graphicRef52988" href="/z/d/graphic/52988.html" rel="external">picture 13</a>), are important dermatologic complications of liver transplantation (<a class="graphic graphic_table graphicRef72557" href="/z/d/graphic/72557.html" rel="external">table 6</a>) [<a href="#rid33">33-40</a>]. Skin cancer is more commonly seen in patients who have undergone liver transplantation than in patients with other immunosuppressed states [<a href="#rid7">7</a>]. Additionally, squamous cell carcinomas tend to be more aggressive in organ transplant recipients compared with the general population [<a href="#rid41">41</a>]. The relatively high incidence of skin cancer is principally due to the effects of three factors:</p><p class="bulletIndent1"><span class="glyph">●</span>Immunosuppression (<a class="graphic graphic_table graphicRef62170" href="/z/d/graphic/62170.html" rel="external">table 8</a> and <a class="graphic graphic_table graphicRef76140" href="/z/d/graphic/76140.html" rel="external">table 9</a>)</p><p class="bulletIndent1"><span class="glyph">●</span>Exposure to sunlight</p><p class="bulletIndent1"><span class="glyph">●</span>Infection with human papilloma virus</p><p></p><p>The diagnosis and management of skin cancer following solid organ transplantation are discussed in detail elsewhere. (See  <a class="medical medical_review" href="/z/d/html/16332.html" rel="external">"Epidemiology and risk factors for skin cancer in solid organ transplant recipients"</a> and  <a class="medical medical_review" href="/z/d/html/16339.html" rel="external">"Prevention and management of skin cancer in solid organ transplant recipients"</a> and  <a class="medical medical_review" href="/z/d/html/7304.html" rel="external">"Malignancy after solid organ transplantation"</a> and  <a class="medical medical_review" href="/z/d/html/4589.html" rel="external">"Liver transplantation in adults: Long-term management of transplant recipients", section on 'De novo malignancy'</a>.)</p><p class="headingAnchor" id="H457175674"><span class="h2">Miscellaneous</span><span class="headingEndMark"> — </span>A variety of uncommon skin disorders may also be seen following liver transplantation (<a class="graphic graphic_table graphicRef67318" href="/z/d/graphic/67318.html" rel="external">table 7</a>) [<a href="#rid4">4,42-52</a>]. These include:</p><p class="bulletIndent1"><span class="glyph">●</span>Graft-versus-host disease (<a class="graphic graphic_picture graphicRef66097" href="/z/d/graphic/66097.html" rel="external">picture 14</a> and <a class="graphic graphic_picture graphicRef59686" href="/z/d/graphic/59686.html" rel="external">picture 15</a>) because the donor liver contains a large number of lymphocytes (see  <a class="medical medical_review" href="/z/d/html/3549.html" rel="external">"Clinical manifestations, diagnosis, and grading of acute graft-versus-host disease", section on 'Skin'</a>)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Cutaneous calcinosis</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Erythema elevatum diutinum (<a class="graphic graphic_picture graphicRef67776" href="/z/d/graphic/67776.html" rel="external">picture 16</a> and <a class="graphic graphic_picture graphicRef57008" href="/z/d/graphic/57008.html" rel="external">picture 17</a>) (see  <a class="medical medical_review" href="/z/d/html/13765.html" rel="external">"Erythema elevatum diutinum"</a>)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Photosensitivity due to pseudoporphyria, transitory porphyrinemia (<a class="graphic graphic_picture graphicRef80856" href="/z/d/graphic/80856.html" rel="external">picture 18</a>)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Porokeratosis (<a class="graphic graphic_picture graphicRef81874" href="/z/d/graphic/81874.html" rel="external">picture 19</a> and <a class="graphic graphic_picture graphicRef73545" href="/z/d/graphic/73545.html" rel="external">picture 20</a>) (see  <a class="medical medical_review" href="/z/d/html/13721.html" rel="external">"Porokeratosis", section on 'Clinical presentation'</a>)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Immune thrombocytopenia (also called idiopathic thrombocytopenic purpura) (<a class="graphic graphic_picture graphicRef76671" href="/z/d/graphic/76671.html" rel="external">picture 21</a>) (see  <a class="medical medical_review" href="/z/d/html/6676.html" rel="external">"Immune thrombocytopenia (ITP) in adults: Clinical manifestations and diagnosis"</a>)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Granuloma annulare (<a class="graphic graphic_picture graphicRef71308" href="/z/d/graphic/71308.html" rel="external">picture 22</a>) (see  <a class="medical medical_review" href="/z/d/html/13705.html" rel="external">"Granuloma annulare: Epidemiology, clinical manifestations, and diagnosis", section on 'Clinical features'</a>)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Alopecia has been reported in 2.7 percent of pediatric liver transplantation recipients [<a href="#rid53">53</a>]</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Malakoplakia as a complication of cutaneous septic vasculitis [<a href="#rid54">54</a>]</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Urticaria due to immunoglobulin E (IgE)-mediated food allergy may develop after liver transplantation [<a href="#rid11">11</a>] </p><p></p><p class="headingAnchor" id="H12"><span class="h1">PREVENTION AND MANAGEMENT</span><span class="headingEndMark"> — </span>Prevention of dermatologic complications following liver transplantation focuses primarily on skin cancer prevention. After liver transplantation, patients should protect themselves from sunlight. We recommend patients wear sun protective clothing and use sunscreens with a sun protection factor (SPF) of 30 or higher, though data are lacking with regard to the minimal SPF patients should use. It is important that the sunscreen chosen protects against the entire spectrum of ultraviolet radiation (UVA and UVB). The sunscreen should be applied 30 minutes before sun exposure and should be reapplied at least every two hours. (See  <a class="medical medical_review" href="/z/d/html/13751.html" rel="external">"Selection of sunscreen and sun-protective measures"</a> and  <a class="medical medical_review" href="/z/d/html/16339.html" rel="external">"Prevention and management of skin cancer in solid organ transplant recipients", section on 'Sun protection'</a>.)</p><p>Chemoprevention for squamous cell carcinoma (SCC) of the skin is discussed separately. (See  <a class="medical medical_review" href="/z/d/html/16339.html" rel="external">"Prevention and management of skin cancer in solid organ transplant recipients", section on 'Chemoprevention for squamous cell carcinoma'</a>.)</p><p>The skin of patients after transplantation should be examined completely and systematically, including the oral, genital, and anal areas [<a href="#rid55">55</a>]. Regular systematic examination of the skin is needed to discover and treat precancerous lesions, such as actinic keratosis (<a class="graphic graphic_picture graphicRef53177" href="/z/d/graphic/53177.html" rel="external">picture 23</a>), verrucae (<a class="graphic graphic_picture graphicRef72502" href="/z/d/graphic/72502.html" rel="external">picture 24</a>), and oral leukoplakia (<a class="graphic graphic_picture graphicRef72711" href="/z/d/graphic/72711.html" rel="external">picture 25</a>). Any suspicious lesions should be examined by a dermatologist. (See  <a class="medical medical_review" href="/z/d/html/16339.html" rel="external">"Prevention and management of skin cancer in solid organ transplant recipients", section on 'Post-transplantation surveillance'</a> and  <a class="medical medical_review" href="/z/d/html/16339.html" rel="external">"Prevention and management of skin cancer in solid organ transplant recipients", section on 'Follow-up'</a>.)</p><p>The early recognition of cutaneous diseases after liver transplantation permits treatment during the mild stages and alerts the transplantation hepatologist that a reduction in the level of immunosuppression may be needed. A declining incidence of keratinocyte carcinoma has been observed following the implementation of routine, periodic dermatologic screening for organ transplant recipients [<a href="#rid38">38,56,57</a>].</p><p>Management of the cosmetic consequences of the immunosuppressive regimen, such as hypertrichosis and sebaceous hyperplasia (<a class="graphic graphic_table graphicRef56452" href="/z/d/graphic/56452.html" rel="external">table 2</a>), enhances the adherence of patients to treatment and their trust in the clinician. In some cases, changing the immunosuppressive regimen may improve dermatologic complications following solid organ transplantation. As an example, in renal transplantation recipients, conversion from calcineurin inhibitors (eg, <a class="drug drug_general" data-topicid="9217" href="/z/d/drug information/9217.html" rel="external">cyclosporine</a>) to <a class="drug drug_general" data-topicid="9971" href="/z/d/drug information/9971.html" rel="external">tacrolimus</a> has been shown to improve hypertrichosis [<a href="#rid58">58</a>]. Also, inhibitors of the mechanistic target of rapamycin (mTOR) kinase have been shown to slow down cutaneous carcinogenesis [<a href="#rid59">59,60</a>] compared with cyclosporine, but they can have multiple side effects such as impaired wound healing [<a href="#rid61">61,62</a>], rashes, and acne.</p><p class="headingAnchor" id="H600075298"><span class="h1">SOCIETY GUIDELINE LINKS</span><span class="headingEndMark"> — </span>Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See  <a class="medical medical_society_guidelines" href="/z/d/html/113977.html" rel="external">"Society guideline links: Liver transplantation"</a>.)</p><p class="headingAnchor" id="H155947760"><span class="h1">SUMMARY AND RECOMMENDATIONS</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Effect of transplantation on pre-existing dermatologic conditions –</strong> Patients undergoing liver transplantation may have preexisting dermatologic disorders that are subsequently affected by transplantation. (See <a class="local">'Effect of transplantation on preexisting dermatologic disorders'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>In patients with dermatologic lesions related to cirrhosis or associated with specific forms of liver disease, transplantation often leads to improvement in the dermatologic findings (<a class="graphic graphic_table graphicRef60813" href="/z/d/graphic/60813.html" rel="external">table 1</a>). Most of the nonspecific mucocutaneous lesions linked to liver cirrhosis, such as palmar erythema, spider nevi, and pruritus, disappear in the weeks following the liver transplantation, though skin pigmentation, clubbing, and fingernail changes may take several months to regress. Dupuytren's contractures are usually irreversible. (See <a class="local">'Dermatologic manifestations of liver disease'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Patients with liver disease may have dermatologic disorders that are not the result of their liver disease, such as psoriasis and atopic dermatitis. In some cases, the immunosuppressive agents used following liver transplantation, such as glucocorticoids and calcineurin inhibitors, may also lead to improvement in dermatologic disorders. However, rapid tapering of immunosuppression could lead to exacerbations of dermatologic disorders. (See <a class="local">'Coexisting dermatologic disorders'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Patients undergoing liver transplantation may have a history of treated skin cancer. While a history of treated skin cancer is not an absolute contraindication to transplantation, if a patient develops a recurrence, a reduction in immunosuppression may be needed, increasing the risk of graft rejection. (See <a class="local">'Previously treated skin cancer'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Dermatologic conditions related to liver transplantation – </strong>New dermatologic lesions may develop following liver transplantation, often related to the patient's immunosuppression. (See <a class="local">'Dermatologic complications after liver transplantation'</a> above.)</p><p></p><p class="bulletIndent1">These include:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Side effects of immunosuppressive therapy, such as acne, hypertrichosis, cushingoid appearance, and immune thrombocytopenia (<a class="graphic graphic_table graphicRef56452" href="/z/d/graphic/56452.html" rel="external">table 2</a>). (See <a class="local">'Cosmetic problems and side effects of immunosuppressive therapy'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Skin infections due to bacteria, viruses, and/or fungi (<a class="graphic graphic_table graphicRef69874" href="/z/d/graphic/69874.html" rel="external">table 3</a> and <a class="graphic graphic_table graphicRef76657" href="/z/d/graphic/76657.html" rel="external">table 4</a> and <a class="graphic graphic_table graphicRef55662" href="/z/d/graphic/55662.html" rel="external">table 5</a>). The infections often involve several infectious agents. Common bacterial and viral infections predominate early (less than three months) after transplantation, while rarer bacteria and opportunistic agents, such as fungi, are seen later. (See <a class="local">'Dermatologic infections'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Skin cancer, particularly squamous cell carcinoma (<a class="graphic graphic_table graphicRef72557" href="/z/d/graphic/72557.html" rel="external">table 6</a> and <a class="graphic graphic_table graphicRef62170" href="/z/d/graphic/62170.html" rel="external">table 8</a>). (See <a class="local">'Skin cancer'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Graft-versus-host disease (<a class="graphic graphic_table graphicRef67318" href="/z/d/graphic/67318.html" rel="external">table 7</a>). (See <a class="local">'Miscellaneous'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Prevention and management –</strong> Prevention of dermatologic complications following liver transplantation focuses primarily on skin cancer prevention. After liver transplantation, patients should protect themselves from sunlight with sun protective clothing and sunscreens with a sun protective factor (SPF) of 30 or higher. In addition, patients' skin should be examined completely and systematically, including the oral, genital, and anal areas. (See  <a class="medical medical_review" href="/z/d/html/16339.html" rel="external">"Prevention and management of skin cancer in solid organ transplant recipients", section on 'Sun protection'</a> and  <a class="medical medical_review" href="/z/d/html/16339.html" rel="external">"Prevention and management of skin cancer in solid organ transplant recipients", section on 'Post-transplantation surveillance'</a>.)</p><p></p><p class="bulletIndent1">Early recognition of cutaneous diseases after liver transplantation permits treatment during the mild stages and alerts the transplantation hepatologist that a reduction in the level of immunosuppression may be needed. In some cases, changing the immunosuppressive regimen may improve dermatologic complications following solid organ transplantation.</p><p></p><p class="headingAnchor" id="H1064498976"><span class="h1">ACKNOWLEDGMENTS</span><span class="headingEndMark"> — </span>The authors and UpToDate thank Edmond Schmied, MD, and Patrick A Oberholzer, MD, who contributed to earlier versions of this topic review.</p></div><div class="headingAnchor" id="references"><ol id="reference"><li><a class="nounderline abstract_t">Christenson LJ, Geusau A, Ferrandiz C, et al. Specialty clinics for the dermatologic care of solid-organ transplant recipients. Dermatol Surg 2004; 30:598.</a></li><li><a class="nounderline abstract_t">Hofbauer GF, Anliker M, Arnold A, et al. Swiss clinical practice guidelines for skin cancer in organ transplant recipients. Swiss Med Wkly 2009; 139:407.</a></li><li><a class="nounderline abstract_t">Tangthanapalakul A, Chaijitraruch N, Techavichit P, et al. Dermatologic manifestations in pediatric patients after liver and HSCT: A 20-year retrospective cohort study. Pediatr Transplant 2021; 25:e13916.</a></li><li><a class="nounderline abstract_t">Hassan G, Khalaf H, Mourad W. Dermatologic complications after liver transplantation: a single-center experience. Transplant Proc 2007; 39:1190.</a></li><li><a class="nounderline abstract_t">Schmied E, Dufour JF, Euvrard S. Nontumoral dermatologic problems after liver transplantation. Liver Transpl 2004; 10:331.</a></li><li><a class="nounderline abstract_t">Belloni-Fortina A, Piaserico S, Bordignon M, et al. Skin cancer and other cutaneous disorders in liver transplant recipients. Acta Derm Venereol 2012; 92:411.</a></li><li><a class="nounderline abstract_t">Ramos HC, Reyes J, Abu-Elmagd K, et al. Weaning of immunosuppression in long-term liver transplant recipients. Transplantation 1995; 59:212.</a></li><li><a class="nounderline abstract_t">Collett D, Mumford L, Banner NR, et al. Comparison of the incidence of malignancy in recipients of different types of organ: a UK Registry audit. Am J Transplant 2010; 10:1889.</a></li><li><a class="nounderline abstract_t">Smith DM, Agura E, Netto G, et al. Liver transplant-associated graft-versus-host disease. Transplantation 2003; 75:118.</a></li><li><a class="nounderline abstract_t">Burdick JF, Vogelsang GB, Smith WJ, et al. Severe graft-versus-host disease in a liver-transplant recipient. N Engl J Med 1988; 318:689.</a></li><li><a class="nounderline abstract_t">Yadav DK, Bai XL, Liang T. Dermatological Disorders following Liver Transplantation: An Update. Can J Gastroenterol Hepatol 2019; 2019:9780952.</a></li><li><a class="nounderline abstract_t">Satapathy SK, Bernstein D. Dermatologic disorders and the liver. Clin Liver Dis 2011; 15:165.</a></li><li><a class="nounderline abstract_t">Marinho RT, Perdigoto R. Images in hepatology. Reversible nail changes in primary biliary cirrhosis after liver transplantation. J Hepatol 1999; 30:330.</a></li><li><a class="nounderline abstract_t">Sale GE. Alopecia in liver transplant recipients. Br J Dermatol 1997; 136:635.</a></li><li><a class="nounderline abstract_t">Tsuboi H, Yonemoto K, Katsuoka K. Vitiligo with inflammatory raised borders with hepatitis C virus infection. J Dermatol 2006; 33:577.</a></li><li><a class="nounderline abstract_t">Schmidt HH, Manns MP. Images in hepatology. Regression of xanthelasmas in a patient with primary biliary cirrhosis after liver transplantation. J Hepatol 1998; 28:1077.</a></li><li><a class="nounderline abstract_t">Patel N, Norberg A, Hogeling M. Planar xanthomas secondary to post-transplantation cholangiopathy in a 16-month-old boy. Pediatr Dermatol 2018; 35:e163.</a></li><li><a class="nounderline abstract_t">Duvoux C, Tran Ngoc A, Intrator L, et al. Hepatitis C virus (HCV)-related cryoglobulinemia after liver transplantation for HCV cirrhosis. Transpl Int 2002; 15:3.</a></li><li><a class="nounderline abstract_t">Poikolainen K, Reunala T, Karvonen J, et al. Alcohol intake: a risk factor for psoriasis in young and middle aged men? BMJ 1990; 300:780.</a></li><li><a class="nounderline abstract_t">Qureshi AA, Dominguez PL, Choi HK, et al. Alcohol intake and risk of incident psoriasis in US women: a prospective study. Arch Dermatol 2010; 146:1364.</a></li><li><a class="nounderline abstract_t">Richard MA, Barnetche T, Horreau C, et al. Psoriasis, cardiovascular events, cancer risk and alcohol use: evidence-based recommendations based on systematic review and expert opinion. J Eur Acad Dermatol Venereol 2013; 27 Suppl 3:2.</a></li><li><a class="nounderline abstract_t">Montaudié H, Sbidian E, Paul C, et al. Methotrexate in psoriasis: a systematic review of treatment modalities, incidence, risk factors and monitoring of liver toxicity. J Eur Acad Dermatol Venereol 2011; 25 Suppl 2:12.</a></li><li><a class="nounderline abstract_t">Otley CC, Hirose R, Salasche SJ. Skin cancer as a contraindication to organ transplantation. Am J Transplant 2005; 5:2079.</a></li><li><a class="nounderline abstract_t">Naldi L, Venturuzzo A, Invernizzi P. Dermatological Complications After Solid Organ Transplantation. Clin Rev Allergy Immunol 2018; 54:185.</a></li><li><a class="nounderline abstract_t">Ilyas M, Colegio OR, Kaplan B, Sharma A. Cutaneous Toxicities From Transplantation-Related Medications. Am J Transplant 2017; 17:2782.</a></li><li><a class="nounderline abstract_t">Ilyas M, Maganty N, Ginsberg Z, Sharma A. Skin Infections due to Bacteria in Solid Organ Transplant Recipients: A Review. Dermatology 2017; 233:358.</a></li><li><a class="nounderline abstract_t">Euvrard S. [Infectious cutaneous pathology after organ transplantation]. Ann Dermatol Venereol 1998; 125:939.</a></li><li><a class="nounderline abstract_t">Barr BB, Benton EC, McLaren K, et al. Papillomavirus infection and skin cancer in renal allograft recipients. Lancet 1989; 2:224.</a></li><li><a class="nounderline abstract_t">Itin PH, Battegay M. Skin problems in immunodeficient patients. Curr Probl Dermatol 2012; 43:9.</a></li><li><a class="nounderline abstract_t">Hofbauer GF, Freiberger SN, Iotzova-Weiss G, et al. Organ transplantation and skin--principles and concepts. Curr Probl Dermatol 2012; 43:1.</a></li><li><a class="nounderline abstract_t">Fattouh K, Ducroux E, Decullier E, et al. Increasing incidence of melanoma after solid organ transplantation: a retrospective epidemiological study. Transpl Int 2017; 30:1172.</a></li><li><a class="nounderline abstract_t">Cahoon EK, Linet MS, Clarke CA, et al. Risk of Kaposi sarcoma after solid organ transplantation in the United States. Int J Cancer 2018; 143:2741.</a></li><li><a class="nounderline abstract_t">Chak E, Saab S. Risk factors and incidence of de novo malignancy in liver transplant recipients: a systematic review. Liver Int 2010; 30:1247.</a></li><li><a class="nounderline abstract_t">Otley CC, Pittelkow MR. Skin cancer in liver transplant recipients. Liver Transpl 2000; 6:253.</a></li><li><a class="nounderline abstract_t">Robbins HA, Clarke CA, Arron ST, et al. Melanoma Risk and Survival among Organ Transplant Recipients. J Invest Dermatol 2015; 135:2657.</a></li><li><a class="nounderline abstract_t">Clarke CA, Robbins HA, Tatalovich Z, et al. Risk of merkel cell carcinoma after solid organ transplantation. J Natl Cancer Inst 2015; 107.</a></li><li><a class="nounderline abstract_t">Funk-Debleds P, Ducroux E, Guillaud O, et al. Subsequent nonmelanoma skin cancers and impact of immunosuppression in liver transplant recipients. J Am Acad Dermatol 2018; 79:84.</a></li><li><a class="nounderline abstract_t">Rizvi SMH, Aagnes B, Holdaas H, et al. Long-term Change in the Risk of Skin Cancer After Organ Transplantation: A Population-Based Nationwide Cohort Study. JAMA Dermatol 2017; 153:1270.</a></li><li><a class="nounderline abstract_t">Garrett GL, Blanc PD, Boscardin J, et al. Incidence of and Risk Factors for Skin Cancer in Organ Transplant Recipients in the United States. JAMA Dermatol 2017; 153:296.</a></li><li><a class="nounderline abstract_t">Mittal A, Colegio OR. Skin Cancers in Organ Transplant Recipients. Am J Transplant 2017; 17:2509.</a></li><li><a class="nounderline abstract_t">Lanz J, Bouwes Bavinck JN, Westhuis M, et al. Aggressive Squamous Cell Carcinoma in Organ Transplant Recipients. JAMA Dermatol 2019; 155:66.</a></li><li><a class="nounderline abstract_t">Derancourt C, Senser M, Atallah L, et al. [Granuloma annulare of the photoexposed areas in two liver transplant recipients]. Ann Dermatol Venereol 2000; 127:723.</a></li><li><a class="nounderline abstract_t">Roberts JP, Ascher NL, Lake J, et al. Graft vs. host disease after liver transplantation in humans: a report of four cases. Hepatology 1991; 14:274.</a></li><li><a class="nounderline abstract_t">Redondo P, España A, Herrero JI, et al. Graft-versus-host disease after liver transplantation. J Am Acad Dermatol 1993; 29:314.</a></li><li><a class="nounderline abstract_t">Jucglà A, Sais G, Curco N, et al. Calcinosis cutis following liver transplantation: a complication of intravenous calcium administration. Br J Dermatol 1995; 132:275.</a></li><li><a class="nounderline abstract_t">Pageaux GP, Perrigault PF, Fabre JM, et al. Lethal acute graft-versus-host disease in a liver transplant recipient: relations with cell migration and chimerism. Clin Transplant 1995; 9:65.</a></li><li><a class="nounderline abstract_t">Blemker AL, Dean RA, Weaver DC, et al. Transient porphyrinemia in a liver transplant recipient. Arch Dermatol 1991; 127:704.</a></li><li><a class="nounderline abstract_t">Sheth AP, Esterly NB, Rabinowitz LG, Poh-Fitzpatrick MB. Cutaneous porphyrialike photosensitivity after liver transplantation. Arch Dermatol 1994; 130:614.</a></li><li><a class="nounderline abstract_t">Takatsuki M, Uemoto S, Kurokawa T, et al. Idiopathic thrombocytopenic purpura after a living-related liver transplantation. Transplantation 1999; 67:479.</a></li><li><a class="nounderline abstract_t">Neumann UP, Kaisers U, Langrehr JM, et al. Fatal graft-versus-host-disease: a grave complication after orthotopic liver transplantation. Transplant Proc 1994; 26:3616.</a></li><li><a class="nounderline abstract_t">Komorowski RA, Clowry LJ. Porokeratosis of mibelli in transplant recipients. Am J Clin Pathol 1989; 91:71.</a></li><li><a class="nounderline abstract_t">Hernández-Cano N, De Lucas R, Lázaro TE, et al. Erythema elevatum diutinum after liver transplantation: disappearance of the lesions associated with a reduction in cyclosporin dosage. Pediatr Dermatol 1998; 15:411.</a></li><li><a class="nounderline abstract_t">Alatas FS, Matsuura T, Yoshimaru K, et al. Alopecia in Children Following Living Related Liver Transplantation. Transplant Proc 2021; 53:228.</a></li><li><a class="nounderline abstract_t">Tomasini C. Malakoplakia complicating cutaneous septic vasculitis in an immunosuppressed liver transplant patient. Eur J Dermatol 2018; 28:848.</a></li><li><a class="nounderline abstract_t">Zwald F, Leitenberger J, Zeitouni N, et al. Recommendations for Solid Organ Transplantation for Transplant Candidates With a Pretransplant Diagnosis of Cutaneous Squamous Cell Carcinoma, Merkel Cell Carcinoma and Melanoma: A Consensus Opinion From the International Transplant Skin Cancer Collaborative (ITSCC). Am J Transplant 2016; 16:407.</a></li><li><a class="nounderline abstract_t">Menzies S, O'Leary E, Callaghan G, et al. Declining incidence of keratinocyte carcinoma in organ transplant recipients. Br J Dermatol 2019; 181:983.</a></li><li><a class="nounderline abstract_t">Chan AW, Fung K, Austin PC, et al. Improved keratinocyte carcinoma outcomes with annual dermatology assessment after solid organ transplantation: Population-based cohort study. Am J Transplant 2019; 19:522.</a></li><li><a class="nounderline abstract_t">Lübbe J, Sorg O, Malé PJ, et al. Sirolimus-induced inflammatory papules with acquired reactive perforating collagenosis. Dermatology 2008; 216:239.</a></li><li><a class="nounderline abstract_t">Euvrard S, Morelon E, Rostaing L, et al. Sirolimus and secondary skin-cancer prevention in kidney transplantation. N Engl J Med 2012; 367:329.</a></li><li><a class="nounderline abstract_t">de Fijter JW. Cancer and mTOR Inhibitors in Transplant Recipients. Transplantation 2017; 101:45.</a></li><li><a class="nounderline abstract_t">Feldmeyer L, Hofbauer GF, Böni T, et al. Mammalian target of rapamycin (mTOR) inhibitors slow skin carcinogenesis, but impair wound healing. Br J Dermatol 2012; 166:422.</a></li><li><a class="nounderline abstract_t">Brewer JD, Otley CC, Christenson LJ, et al. The effects of sirolimus on wound healing in dermatologic surgery. Dermatol Surg 2008; 34:216.</a></li></ol></div><div id="topicVersionRevision">Topic 4594 Version 26.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15061842" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : Specialty clinics for the dermatologic care of solid-organ transplant recipients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19680830" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : Swiss clinical practice guidelines for skin cancer in organ transplant recipients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33142028" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : Dermatologic manifestations in pediatric patients after liver and HSCT: A 20-year retrospective cohort study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17524929" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : Dermatologic complications after liver transplantation: a single-center experience.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15004757" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : Nontumoral dermatologic problems after liver transplantation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22377797" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : Skin cancer and other cutaneous disorders in liver transplant recipients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7839442" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : Weaning of immunosuppression in long-term liver transplant recipients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20659094" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : Comparison of the incidence of malignancy in recipients of different types of organ: a UK Registry audit.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12544883" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : Liver transplant-associated graft-versus-host disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3278235" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : Severe graft-versus-host disease in a liver-transplant recipient.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31058114" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : Dermatological Disorders following Liver Transplantation: An Update.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21111999" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : Dermatologic disorders and the liver.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10068115" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : Images in hepatology. Reversible nail changes in primary biliary cirrhosis after liver transplantation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9155979" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : Alopecia in liver transplant recipients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16923143" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : Vitiligo with inflammatory raised borders with hepatitis C virus infection.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9672187" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : Images in hepatology. Regression of xanthelasmas in a patient with primary biliary cirrhosis after liver transplantation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29575286" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : Planar xanthomas secondary to post-transplantation cholangiopathy in a 16-month-old boy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11875606" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : Hepatitis C virus (HCV)-related cryoglobulinemia after liver transplantation for HCV cirrhosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1969757" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : Alcohol intake: a risk factor for psoriasis in young and middle aged men?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20713772" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : Alcohol intake and risk of incident psoriasis in US women: a prospective study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23845148" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : Psoriasis, cardiovascular events, cancer risk and alcohol use: evidence-based recommendations based on systematic review and expert opinion.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21388454" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : Methotrexate in psoriasis: a systematic review of treatment modalities, incidence, risk factors and monitoring of liver toxicity.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16095486" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : Skin cancer as a contraindication to organ transplantation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29177692" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : Dermatological Complications After Solid Organ Transplantation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28452165" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : Cutaneous Toxicities From Transplantation-Related Medications.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29316554" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : Skin Infections due to Bacteria in Solid Organ Transplant Recipients: A Review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9922876" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : [Infectious cutaneous pathology after organ transplantation].</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2568556" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : Papillomavirus infection and skin cancer in renal allograft recipients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22377916" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : Skin problems in immunodeficient patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22377915" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : Organ transplantation and skin--principles and concepts.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28700114" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : Increasing incidence of melanoma after solid organ transplantation: a retrospective epidemiological study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29987894" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : Risk of Kaposi sarcoma after solid organ transplantation in the United States.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20602682" id="rid32" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>33 : Risk factors and incidence of de novo malignancy in liver transplant recipients: a systematic review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10827224" id="rid33" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>34 : Skin cancer in liver transplant recipients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26270022" id="rid34" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>35 : Melanoma Risk and Survival among Organ Transplant Recipients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25575645" id="rid35" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>36 : Risk of merkel cell carcinoma after solid organ transplantation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29307647" id="rid36" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>37 : Subsequent nonmelanoma skin cancers and impact of immunosuppression in liver transplant recipients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29049612" id="rid37" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>38 : Long-term Change in the Risk of Skin Cancer After Organ Transplantation: A Population-Based Nationwide Cohort Study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28097368" id="rid38" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>39 : Incidence of and Risk Factors for Skin Cancer in Organ Transplant Recipients in the United States.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28556451" id="rid39" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>40 : Skin Cancers in Organ Transplant Recipients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30516812" id="rid40" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>41 : Aggressive Squamous Cell Carcinoma in Organ Transplant Recipients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11011163" id="rid41" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>42 : [Granuloma annulare of the photoexposed areas in two liver transplant recipients].</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1860684" id="rid42" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>43 : Graft vs. host disease after liver transplantation in humans: a report of four cases.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8340506" id="rid43" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>44 : Graft-versus-host disease after liver transplantation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7888367" id="rid44" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>45 : Calcinosis cutis following liver transplantation: a complication of intravenous calcium administration.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7742585" id="rid45" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>46 : Lethal acute graft-versus-host disease in a liver transplant recipient: relations with cell migration and chimerism.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2024989" id="rid46" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>47 : Transient porphyrinemia in a liver transplant recipient.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7910008" id="rid47" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>48 : Cutaneous porphyrialike photosensitivity after liver transplantation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10030298" id="rid48" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>49 : Idiopathic thrombocytopenic purpura after a living-related liver transplantation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7998294" id="rid49" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>50 : Fatal graft-versus-host-disease: a grave complication after orthotopic liver transplantation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2642639" id="rid50" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>51 : Porokeratosis of mibelli in transplant recipients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9796601" id="rid51" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>52 : Erythema elevatum diutinum after liver transplantation: disappearance of the lesions associated with a reduction in cyclosporin dosage.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32605770" id="rid52" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>53 : Alopecia in Children Following Living Related Liver Transplantation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30530424" id="rid53" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>54 : Malakoplakia complicating cutaneous septic vasculitis in an immunosuppressed liver transplant patient.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26820755" id="rid54" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>55 : Recommendations for Solid Organ Transplantation for Transplant Candidates With a Pretransplant Diagnosis of Cutaneous Squamous Cell Carcinoma, Merkel Cell Carcinoma and Melanoma: A Consensus Opinion From the International Transplant Skin Cancer Collaborative (ITSCC).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31049932" id="rid55" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>56 : Declining incidence of keratinocyte carcinoma in organ transplant recipients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29900669" id="rid56" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>57 : Improved keratinocyte carcinoma outcomes with annual dermatology assessment after solid organ transplantation: Population-based cohort study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18182818" id="rid57" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>58 : Sirolimus-induced inflammatory papules with acquired reactive perforating collagenosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22830463" id="rid58" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>59 : Sirolimus and secondary skin-cancer prevention in kidney transplantation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27547865" id="rid59" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>60 : Cancer and mTOR Inhibitors in Transplant Recipients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21895616" id="rid60" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>61 : Mammalian target of rapamycin (mTOR) inhibitors slow skin carcinogenesis, but impair wound healing.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18093198" id="rid61" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>62 : The effects of sirolimus on wound healing in dermatologic surgery.</p>
</a>
</div>
</div>
</div>
</div>
</section>
</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->
<!-- End Footer Area -->
<!-- Back to top -->
<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->
<!-- Prpper JS -->
<!-- Bootstrap Min JS -->
<!-- Classy Nav Min Js -->
<!-- Owl Carousel Min Js -->
<!-- Magnific Popup JS -->
<!-- CounterUp JS -->
<!-- Waypoints JS -->
<!-- Form Validator Min JS -->
<!-- Contact Form Min JS -->
<!-- Main JS -->
<!-- Global site tag (gtag.js) - Google Analytics -->
</body>
</html>
